Sign inJoin waitlistJoin the waitlist

Seema Naik

Professor, Department of Medicine · Penn State Milton S Hershey Medical Center

Credentials: · · · · · · ·

History

Penn State Milton S Hershey Medical Center
Present

Bone Marrow Transplant Stanford Cancer Center Palo Alto
2008–2009
Hematology and Medical Oncology
One Brooklyn Health System-Brookdale University Hospital Medical Center
2005–2008
Internal Medicine
Flushing Hospital Medical Center
2002–2005
LOKMANYA TILAK MUN MED COLL, BOMBAY UNIV, BOMBAY, MAHARASHTRA
1987–1991

Research

VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
OncoImmunology · 2018 · 150 citations
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
Blood · 2021 · 94 citations
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
Nature Medicine · 2024 · 93 citations

Shin Mineishi
21 papers
Hong Zheng
18 papers
KR
Kevin Rakszawski
18 papers · 1 as a fellow
Christopher Ehmann
17 papers
DC
David Claxton
16 papers
Kentaro Minagawa
14 papers
Myles Nickolich
14 papers
Witold Rybka
13 papers
Narendranath Epperla
11 papers
BW
Baldeep Wirk
10 papers
Hiroko Shike
10 papers
Joseph Cioccio
10 papers · 4 as a fellow

Clinical trials

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Principal investigator · Terminated · Phase 1, Phase 2
Milton S. Hershey Medical Center
2020–2021
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
Principal investigator · Terminated · Phase 2
Milton S. Hershey Medical Center
2020–2022
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2019–2029